MedPath

Peking University Third Hospital (Peking University Third Clinical Medical College)

🇨🇳China
Ownership
-
Employees
-
Market Cap
-
Website

Retrospective Clinical Study of Excessive Lateral Pressure Syndrome

Terminated
Conditions
Excessive Lateral Pressure Syndrome
Interventions
Procedure: extracapsular release of lateral retinaculum
First Posted Date
2021-07-27
Last Posted Date
2021-07-27
Lead Sponsor
Peking University Third Hospital
Target Recruit Count
100
Registration Number
NCT04977492

Study of Nimotuzumab Combined With IMRT in Elder Patients With Cervical Squamous Cell Carcinoma

Not yet recruiting
Conditions
Cervical Squamous Cell Carcinoma
Interventions
Drug: Nimotuzumab
Radiation: EBRT combined with brachytherapy
First Posted Date
2021-07-26
Last Posted Date
2021-07-26
Lead Sponsor
Peking University Third Hospital
Target Recruit Count
125
Registration Number
NCT04976478
Locations
🇨🇳

Peking University 3rd Hospital, Beijing, Beijing, China

Men and Women With Different Designs and Semi-individual Total Knee Replacement

Not Applicable
Not yet recruiting
Conditions
Arthroplasty, Replacement, Knee
Interventions
Procedure: semi-individualized total knee replacement treatment with a gender-specific design
Procedure: Zimmer total knee replacement prostheses (Zimmer, Warsaw, IN, USA)
First Posted Date
2021-07-26
Last Posted Date
2021-07-26
Lead Sponsor
Peking University Third Hospital
Target Recruit Count
1600
Registration Number
NCT04976400

Research on Optimization of Rotator Cuff Injury Diagnosis Plan

Conditions
Rotator Cuff Injury
Interventions
Behavioral: several physical examinations
First Posted Date
2021-07-22
Last Posted Date
2021-07-22
Lead Sponsor
Peking University Third Hospital
Target Recruit Count
200
Registration Number
NCT04973995

Cartilage Injury and Remodeling After ACL Rupture and Reconstruction: Functional Imaging and Biomarkers

Conditions
Anterior Cruciate Ligament Injuries
Interventions
Procedure: ACL reconstruction
First Posted Date
2021-07-21
Last Posted Date
2021-07-21
Lead Sponsor
Peking University Third Hospital
Target Recruit Count
76
Registration Number
NCT04970706
Locations
🇨🇳

Peking university third hospital, Beijing, Beijing, China

Flupentixol and Melitracen Tablets in the Treatment of Emotional Disorder

Phase 4
Completed
Conditions
Emotional Disorder
Neurologic Disorder
Interventions
First Posted Date
2021-07-21
Last Posted Date
2021-07-21
Lead Sponsor
Peking University Third Hospital
Target Recruit Count
100
Registration Number
NCT04970667
Locations
🇨🇳

Peking University Third Hospital, Beijin, China

Exercise Adherence in Home-based Cardiac Rehabilitation

Conditions
Coronary Artery Disease
Interventions
Other: survey
First Posted Date
2021-07-21
Last Posted Date
2021-07-21
Lead Sponsor
Peking University Third Hospital
Target Recruit Count
300
Registration Number
NCT04970979
Locations
🇨🇳

Peking University Third Hospital, Beijing, China

Risk Factors Analysis After Anterior Cervical Surgery

Conditions
Cervical Spondylosis
Interventions
Other: Medical records collection
First Posted Date
2021-07-21
Last Posted Date
2021-07-21
Lead Sponsor
Peking University Third Hospital
Target Recruit Count
100
Registration Number
NCT04970628
Locations
🇨🇳

Peking University Third Hospital, Beijing, Beijing, China

Mechanism of Xinglouchengqi Decoction in Improving Nerve Injury in the Acute Stage of Stroke by EEG and Metabolomics

Conditions
Stroke
Interventions
Drug: Xinglouchengqi decoction
First Posted Date
2021-07-21
Last Posted Date
2021-07-21
Lead Sponsor
Peking University Third Hospital
Target Recruit Count
30
Registration Number
NCT04970797

Effect of Chewing Gum on Abdominal Distension in Patients After Lumbar Spine Surgery

Not Applicable
Completed
Conditions
Lumbar Spondylosis
Interventions
Procedure: Gum chewing
First Posted Date
2021-07-21
Last Posted Date
2021-07-21
Lead Sponsor
Peking University Third Hospital
Target Recruit Count
50
Registration Number
NCT04970732
Locations
🇨🇳

Peking University Third Hospital, Beijing, Beijing, China

© Copyright 2025. All Rights Reserved by MedPath